Today news
About the same in other media
US judge rules against Corcept in patent infringement spat with Teva
Reading now: 542
(Reuters) — A U.S. judge on Friday ruled against Corcept Therapeutics (NASDAQ:CORT) in a patent infringement lawsuit the pharmaceutical firm had brought against Teva Pharmaceutical (NYSE:TEVA), sparking a frenzied stock sell-off.
Shares of Corcept fell 38% in trading after the bell.
The company had failed to demonstrate a likelihood of direct infringement of its patent by Teva, a United States district judge ruled.
Teva has been selling a generic version of Corcept's Korlym (mifepristone) drug, which is used to treat Cushing’s Syndrome.
«Corcept failed to introduce credible record evidence that
anyone has ever previously infringed the asserted claims,» the ruling stated.
Read more on investing.comAbout this in other media
Jeffrey Epstein document release LIVE Updates: Confidential documents unsealed by US judge livemint.com /4 months ago
More electric vehicles lose tax credits due to battery sourcing rules in US livemint.com /4 months ago
Shale Is Keeping the World Awash With Oil as Conflicts Abound livemint.com /4 months ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
